Literature DB >> 1174390

Elevation of serum immunoglobulin M (IgM) level in patients with brain tumors.

T Tokumaru, L W Catalano.   

Abstract

Sera of 43 brain tumor patients were analyzed along with various other control groups for serum immunoglobulin, cold and sheep cell hemagglutinin and a heterophile type antibody. Serum IgM and heterophile antibody (non-Forssman type) were found elevated in brain tumor and various acute viral meningoencephalitis groups. Serum IgA and IgG levels were essentially unchanged. IgM levels appear to be particularly stimulated by the meningioma class because the removal of tumor from the host was accompanied by its return to normal range. This system of IgM measurement may prove to be a valuable tool in preliminary diagnosis of brain tumors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174390

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  5 in total

1.  Serum IgM level as an index of malignancy in brain tumours.

Authors:  N Hekim; E Sayin; E Demirkaya; F Berkay
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

Review 2.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

3.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

4.  Immunohistochemical demonstration of IgG in meningioma.

Authors:  K Tabuchi; Y Kawakami; A Nishimoto
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

5.  Serum MBP immunoreactivity and immunoglobulin level as markers of tumour type.

Authors:  P A Seeldrayers; N R Hoyle; D G Thomas
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.